March 20 (Reuters) - BIOVICA INTERNATIONAL AB:
* RECEIVED AN ORDER FOR COMPANY’S DIVITUM® PRODUCT FROM A GLOBAL DIAGNOSTIC AND CONTRACT RESEARCH COMPANY
* HAS RECEIVED AN ORDER FOR COMPANY’S DIVITUM® PRODUCT FROM A GLOBAL DIAGNOSTIC AND CONTRACT RESEARCH COMPANY (CRO COMPANY) Source text for Eikon: Further company coverage: (Gdynia Newsroom)